Next generation solvent contributes to next generation biofuel production from biomass
The first-generation biofuel, industrialized, ethanol, is produced from foodstuffs like maize, and thus poses great concern about a possible future shortage of food. It is therefore necessary to produce ethanol from non-food biomass like weeds, waste paper, paper cup, etc. (second-generation biofuel ethanol). solvents needed for the production of second-generation biofuel ethanol known so far are highly toxic to microorganisms. In order to remove such highly toxic solvents, complicated processes are necessary, such as washing with water, separation by centrifugation, compression, etc. As a result, the energy recovered in the ethanol so produced is less than that required to produce it, i.e., there is a negative energy balance (more production of ethanol imposes more load on the environment). It was considered impossible to solve this problem, since a harsh solvent was needed to break down recalcitrant plant materials like cellulose, while such a harsh solvent would kill microorganisms (with fragile and very vulnerable cell membranes) that play essential roles in the fermentation necessary for producing ethanol.
After dissolving plant biomass by the novel solvent, carboxylate-type liquid zwitterion, hydrolysis and fermentation were consecutively carried out in one reaction pot for conversion into ethanol.
Kanazawa University
In the present study, researchers of Kanazawa University, Japan, attacked this problem; they succeeded in reducing the toxicity to microorganisms by developing a novel solvent, a carboxylate-type liquid zwitterion*1, for dissolving biomass cellulose (Figure 1). The EC50, the concentration of a substance that reduces the growth of Escherichia coli to 50%, was found to be 158 g/L for the newly developed carboxylate-type liquid zwitterion, whereas the EC50 of ionic liquid*2, one of the conventional solvents of cellulose, was 9 g/L. This indicates that the novel carboxylate-type liquid zwitterion shows 17 fold lower toxicity than the ionic liquid.
With Escherichia coli that can produce ethanol, fermentation ability was examined and revealed to be almost maximal in 0.5 mol/L carboxylate-type liquid zwitterion with a final ethanol concentration of 21 g/L. On the other hand, the same experiment with the ionic liquid produced only 1 g/L ethanol. Thus, fermentation in the presence of the carboxylate-type liquid zwitterion produced 21 times more ethanol than that using the ionic liquid.
In another experiment, bagasse was used as a starting plant biomass for ethanol production without washing/separation processes. Fermentation in the presence of the carboxylate-type liquid zwitterion produced 1.4 g/L ethanol, while no ethanol was obtained with the ionic liquid due to its high toxicity (Figure 2).
With these experimental results, it is shown that, using the carboxylate-type liquid zwitterion, plant biomass could be converted into ethanol in a single reaction pot without washing/separation processes. This should be a big step forward in the production/utilization of second-generation biofuel ethanol through reducing large amounts of energy input.
Besides the first-generation and second-generation biofuel ethanol, a third-generation biofuel, a kind of oil, may be made from some algal species. In order to obtain such a third-generation biofuel from algae, polysaccharides like cellulose, which are main components of cell walls, have to be dissolved. The energy efficiency would be much increased if dissolved polysaccharides could be converted into ethanol. Further development of our current study would significantly contribute to the production of not only second-generation but also third-generation biofuel ethanol.
Furthermore, a lot of attention has been attracted by the unique characteristics of the carboxylate-type liquid zwitterion, and three international collaborations are currently going on, one of which is with Rutgers University, U.S.A.
Original publication
Other news from the department science
Most read news
More news from our other portals
Last viewed contents
Modeling NAFLD with human pluripotent stem cell derived immature hepatocyte like cells
Agilent Thought Leader Award Presented to Renowned Drug Discovery Researcher Professor - Award to Chinese Scientist Supports the Use of Various Molecular Approaches to Cancer Research
Vitamins doing gymnastics: Scientists capture first full image of vitamin B12 in action - Work by University of Michigan and MIT team yields new understanding of crucial reaction in the body and in CO2-scrubbing bacteria
Positive Results in Proof-of-Concept Study with Sustained Release Treatment for Uveitis
Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan - Abbott will retain its branded generics pharmaceuticals business in emerging markets
Stanford researchers explore link between human birth defect syndrome, cancer metastasis
Asia-Pacific continues to drive global healthcare investment, innovation and growth ASEAN - A US$150 billion healthcare market by 2017, says Frost & Sullivan
Pharmacogenomics study finds rare gene variants critical for personalized drug treatment
Cambridge-based Startup Develops World’s Fastest Coronavirus-Killing Antiviral Protection
Evolva shareholders approve all Board proposals in AGM: Green light for Abunda acquisition
Aragen Bioscience, Inc. and CEVEC Sign License Agreement for Human CAP and CAP-T Technology
